In the news

EKF-diagnostic GmbH part of new medical engineering network 10^th Sep 2014	Webinar: A Novel Method of Studying DNA Damage 27^th Aug 2014
EKF Diagnostics Growing Product Portfolio Highlighted at AACC 2014 23^rd Jul 2014	New data using EKF PointMan™ 21^st Jul 2014
Contract win and regulatory approval 8^th Jul 2014	Stanbio Life Sciences re-branded 1^st Jul 2014
EKF collaborator to deliver Kelly West Lecture at ADA 9^th Jun 2014	EKF Molecular Diagnostics and GILUPI announce CTC DNA enrichment success 29^th May 2014
Studies validate early stage test for progressive Diabetic Kidney Disease 22^nd May 2014	Selah to provide testing services for Women's Health 20^th May 2014
EKF Diagnostics launches Premium Partnership Program 6^th May 2014	New Lactate Scout+ analyzer launched 16^th Apr 2014
EKF announces acquisition of Separation Technology, Inc. 27^th Mar 2014	EKF highlights ultra-sensitive cancer mutation detection kits at AACR 24^th Mar 2014
Proposed acquisitions of Selah Genomics, Inc. and DiaSpect Medical AB 20^th Mar 2014	PointMan at Tri-Con 2014 10^th Feb 2014
PointMan™ successfully enriches low-level mutations in DNA extracted from blood 20^th Jan 2014	EKF Diagnostics' Quo-Lab HbA1c analyzer secures IFCC Certification 8^th Jan 2014
EKF Diagnostics exhibits new POC testing technology at Arab Health 7^th Jan 2014

Reset

EKF Diagnostics

EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.

News & events

PointMan at Tri-Con 2014

EKF Molecular Diagnostics is exhibiting its ground-breaking PointMan™ DNA-enrichment technology at Tri-Con 2014 in San Francisco, CA, Booth #417, 10-14th February.

PointMan™ successfully enriches low-level mutations in DNA extracted from blood

EKF Diagnostics Holdings plc announces a major breakthrough for its PointMan technology for potential use in future cancer testing and treatment.

EKF Diagnostics' Quo-Lab HbA1c analyzer secures IFCC Certification

Point-of-care analyzer meets all standards set by independent certifying bodies.

EKF Diagnostics exhibits new POC testing technology at Arab Health

HbA1c and ß-HB analyzers enable rapid assessment of diabetes and related conditions.